Literature DB >> 807661

Nonenzymatic conversion of human hexosaminidase A.

E Beutler, D Villacorte, W Kuhl, E Guinto, S Srivastava.   

Abstract

Incubation of purified hexosaminidase A with merthiolate, parahydroxymercuribenzoic acid, or silver ions resulted in the formation of an enzyme which was identical, in all respects tested, with hexosaminidase B. Its electrophoretic mobility was identical to hexasaminidase B at three different pH levels. Its chromatographic properties, thermostability, and immunologic reactivity with specific anti-hexosaminidase A and anti-hexosaminidase B antisera were indistinguishable from hexosaminidase B. Conversion could be prevented by GSH but was not reversed by GSH once it had occurred. Conversion of hexosaminidase A to hexosaminindase B was accompanied by the appearance of an electrophoretically rapid, catalytically inactive protein. Hexosaminidase B, itself, was unaltered by incubation with merthiolate. These findings support a previously proposed model of hexosaminidase structure in which hexosaminidase A is (alphabeta)3 and hexosamindase B is (betabeta)2. On treatment of hexosaminidase A with merthiolate and other converting agents alpha and beta subunits are presumably dissociated and they reassociate as (betabeta)3, that is, hexosaminidase B. The expected free or polymerized catalytically inactive, alpha chains are detected on acrylamide gel electrophoresis. We suggest that the catalytic site of human hexosaminidase may be present only on the beta subunit and that the alpha subunit influences the substrate specificity of the enzyme, particularly as directed toward GM2.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807661

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  The subunits of human hexosaminidase A.

Authors:  E Beutler; A Yoshida; W Kuhl; J E Lee
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

3.  Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.

Authors:  Y Ben-Yoseph; J E Reid; B Shapiro; H L Nadler
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

Review 4.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

Review 5.  The biochemical genetics of the hexosaminidase system in man.

Authors:  E Beutler
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

6.  Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.

Authors:  E Beutler
Journal:  West J Med       Date:  1977-01

7.  The multiple forms and kinetic properties of the N-acetyl-beta-D-hexosaminidases from colonic tumours and mucosa of rats treated with 1,2-dimethylhydrazine.

Authors:  N Mian; D G Herries; D M Cowen; E A Batte
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

8.  Thermal activation of hexosaminidase A in a genetic compound with Tay-Sachs disease.

Authors:  Y Ben-Yoseph; M S Baylerian; T Momoi; H L Nadler
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

9.  Interrelationship of hexosaminidases A and B: conformation of the common and the unique subunit theory.

Authors:  S K Srivastava; J E Wiktorowicz; Y C Awasthi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Ischemia-reperfusion injury of adipofascial tissue: an experimental study evaluating early histologic and biochemical alterations in rats.

Authors:  Yusuf Kenan Coban; Ergul Belge Kurutas; Harun Ciralik
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.